Severe visual-field constriction and side-effects of GABA-mimetic antiepileptic agents

Lancet

Volumn 352, Issue 9127, 1998, Pages 546-

  Baulac, Michel ^a   Nordmann, Jean Philippe ^b,c   Lanoé, Yves ^b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL TENON   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; PHENOBARBITAL; PROGABIDE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

EID: 0032529310     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79254-0     Document Type: Article

References (5)

1. 1 Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997; 314: 180-81.
2. 2 Mackenzie R, Klistorner A. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ 1998; 316: 233.
3. 3 Morselli PL, Lloyd KG, Palminteri R. Progabide. In: Lewy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs, 4th edn. New York: Raven Press, 1995: 997-1009.
4. 4 Sieghart W. Structure and pharmacology of γ-aminobutyric acid receptor sub-types. Pharmacol Rev 1995; 47: 181-234.
5. 5 Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998; 50: 614-18.